Intestinal Cell News Volume 8.06 | Feb 18 2022

    0
    15






    2022-02-18 | ICN 8.06


    Intestinal Cell News by STEMCELL Technologies
    Vol. 8.06 – 18 February, 2022
    TOP STORY

    Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell-Like Features by Manipulating Lipid Droplet-Mediated Numb Degradation

    The authors showed that Fusobacterium nucleatum promoted colorectal cancer stem-like cells (CCSCs) self-renewal, and non-CCSCs to acquire CCSC features by manipulating cellular lipid accumulation.
    [Advanced Science]

    Full Article

    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    PUBLICATIONSRanked by the impact factor of the journal

    IL-22 Initiates an IL-18-Dependent Epithelial Response Circuit to Enforce Intestinal Host Defence

    Researchers showed that IL-18 was a bona fide IL-22-regulated gate keeper for intestinal epithelial barrier.
    [Nature Communications]

    Full Article

    BCL-XL Inhibition Induces an FGFR4-Mediated Rescue Response in Colorectal Cancer

    Scientists screened a compound library for synergy with low-dose BCL-XL inhibitor A-1155463 to identify pathways that regulated sensitivity to BCL-XL inhibition and revealed that fibroblast growth factor receptor 4 (FGFR4) inhibition effectively sensitized to A-1155463 both in vitro and in vivo.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Suspension Culture Promotes Serosal Mesothelial Development in Human Intestinal Organoids

    Researchers described suspension culture as a simple, low-maintenance method for culturing human intestinal organoids and for promoting in vitro differentiation of an organized serosal mesothelial layer that was similar to primary human intestinal serosal mesothelium.
    [Cell Reports]

    Full ArticleGraphical Abstract

    LINC01021 Maintains Tumorigenicity by Enhancing N6-Methyladenosine Reader IMP2 Dependent Stabilization of MSX1 and JARID2: Implication in Colorectal Cancer

    Scientists demonstrated that oncogenic LINC021 specifically bound with the m6A “reader” insulin-like growth factor-2 mRNA-binding protein 2 (IMP2) protein and enhanced the mRNA stability of MSX1 and JARID2 in an m6A regulatory manner during colorectal cancer tumorigenesis and pathogenesis.
    [Oncogene]

    Abstract

    Spatial Expression of IKK-Alpha Is Associated with a Differential Mutational Landscape and Survival in Primary Colorectal Cancer

    A mutational tumor profile was examined using a customized gene panel. Immunofluorescence was used to identify the cellular location of punctate IKKα expression.
    [British Journal of Cancer]

    Full Article

    Hypermethylation of PDX1, EN2, and MSX1 Predicts the Prognosis of Colorectal Cancer

    Researchers validated that PDX1, EN2 and MSX1 genes had oncogenic features in colorectal cancer and that their expression levels were increased in correlation with the hypermethylation of intragenic regions.
    [Experimental & Molecular Medicine]

    Full Article

    METTL3 Overexpression Aggravates LPS-Induced Cellular Inflammation in Mouse Intestinal Epithelial Cells and DSS-Induced IBD in Mice

    Within LPS-treated MODE-K cells, METTL3 knockdown promoted cell viability, inhibited cell apoptosis, decreased apoptotic caspase3/9 cleavage, and decreased the levels of proinflammatory cytokines and inflammatory enzymes.
    [Cell Death Discovery]

    Full Article

    Cold Atmospheric Plasma Differentially Affects Cell Renewal and Differentiation of Stem Cells and APC-Deficient-Derived Tumor Cells in Intestinal Organoids

    Scientists addressed the relevance of 3D organoid technology to investigate the biological effects of cold atmospheric plasma on normal epithelial stem cells and tumor cells isolated from mouse small intestine.
    [Cell Death Discovery]

    Full Article

    Request a free copy of the Growing Organoids from Stem Cells Wallchart
    REVIEWS

    Sphingosine 1-Phosphate Modulation and Immune Cell Trafficking in Inflammatory Bowel Disease

    The authors summarize the critical mediators and mechanisms involved in immune cell trafficking in IBD and the available evidence for efficacy, safety and pharmacokinetics of sphingosine 1-phosphate receptor modulators in IBD and other immune-mediated disorders.
    [Nature Reviews Gastroenterology & Hepatology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Celularity Receives Orphan Drug Designation from US FDA for Its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/Neu Positive Gastric and Gastroesophageal Junction Cancers

    Celularity, Inc. announced the US FDA has granted Orphan Drug Designation for its investigational natural killer cell therapy, CYNK-101, for treatment of gastric/gastroesophageal junction cancer.
    [Celularity Inc.]

    Press Release

    FEATURED EVENT

    Cell Symposium: Viruses in Health and Disease

    March 19 – 22, 2022
    Sitges, Spain

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Intestinal Organoid

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Positions – Molecular Cancer Research

    University of Copenhagen – Copenhagen, Denmark

    Research Associate – Gastroenterology

    The University of British Columbia – Vancouver, British Columbia, Canada

    Postdoctoral Fellow – Intestinal Inflammation

    University of North Dakota – Grand Forks, North Dakota, United States

    Research Fellow – Adenocarcinoma

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter